Hematuria in anticoagulated patients with atrial fibrillation and urologic cancer

Abstract Background Based on their renal excretion, direct oral anticoagulants (DOACs) may increase the risk of hematuria in patients with atrial fibrillation (AF) and urologic cancer compared with vitamin K antagonists. Objectives To examine the risk of bleeding associated with DOAC versus warfarin...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Anne Gulbech Ording, Mette Søgaard, Flemming Skjøth, Erik Lerkevang Grove, Gregory Y. H. Lip, Torben Bjerregaard Larsen, Peter Brønnum Nielsen
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2022-01-01
Serija:	Research and Practice in Thrombosis and Haemostasis
Teme:	anticoagulants atrial fibrillation hematuria urologic neoplasms warfarin
Online dostop:	https://doi.org/10.1002/rth2.12629
Oznake:	Označite Brez oznak, prvi označite!